18 th Annual Hospital Medicine Conference Accreditation and Disclosures

Accreditation Statement

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical

Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University Feinberg School of Medicine designates this enduring activity for a maximum of 15.5 AMA PRA

Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Description

This educational initiative was developed to provide a forum for discussing and presenting laboratory and clinical research

concerning the care of patients by hospitalists. The meeting is designed to facilitate a discussion of latest multidisciplinary

techniques for hospitalists. Seventy-five percent of hospitalists now care for patients in the Intensive Care Unit, indicating a pressing

need for competency-based education targeted at the management of critically ill patients. The goal of the pre-course is to provide

clinically relevant evidenced-based updates on essential components of critical care including sepsis, acute respiratory distress

syndrome, liberation from mechanical ventilation, and cardiogenic shock.

Educational Objectives

 Explain current challenges and opportunities for hospital-based healthcare professionals

 Describe approaches to clinical reasoning and diagnosis 1

 Define methods to improve physical exam skills 2

 Summarize evidence-based strategies for treatment of acute decompensated heart failure 3

 Describe optimal approaches to management of patients with cirrhosis

 Explain strategies for evaluating and mitigating risks for complications in the perioperative period

 Summarize the most relevant and potentially practice-changing clinical research related to hospital medicine from the past



Target Audience

This CME program is designed to meet the educational needs of Hospital Medicine Physicians, Physician Assistants, Nurse

Practitioners, and Residents.


Evaluation for CME

To claim Continuing Medical Education, attendees must:

– Listen to the entire session

– Complete the accompanying evaluation


Exhibit Support


– AbbVie

– Bayer

– Boehringer Ingelheim

– Gilead

– Janssen Pharmaceuticals


– AstraZeneca

– Melinta Therapeutics

– Merck & Co Inc

– Novartis

– Pfizer

– Society of Hospital Medicine



Unapproved Uses of Drugs/Devices: In accordance with requirements of the FDA, the audience is advised that information presented

in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please

refer to the FDA approved package insert for each drug/device for full prescribing/utilization information.

Disclosure of financial relationships for CME activity planners, faculty, and others in control of content

In concordance with the ACCME “Standards for Integrity and Independence in Accredited Continuing Education”, all individuals in

control of educational content must disclose all financial relationships with any ineligible company over the past 24 months. An

ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare

products used by or on patients. The purpose of identifying and disclosing financial relationships is to protect the integrity of our

learning environment from industry influence. The existence of a financial relationships does not preclude an individual from

participating in a CME activity, nor does it necessarily imply bias. All financial relationships are reviewed to determine whether they

are relevant to the education, and relevant financial relationships are mitigated in advance of the activity. Mitigation may involve,

but is not limited to, an independent review of the content or planning process.

FSM’s CME Leadership, Review Committee, and Staff have no relevant financial relationships with ineligible companies to


The course directors, planners and faculty of this activity have disclosed the following:

Justin Boike, MD, MPH: Consulting Fee from W.L. Gore and Associates, Inc and Fujifilm Healthcare Americas Corporation. These

financial relationships have ended.

Katherine Carroll, MD: Speakers Bureau from AbbVie and Eli Lilly and Company; Paid Consultant for Eli Lilly and Company. These

financial relationships have ended.

Karlyn Martin, MD, MS: Grant or Research Support from Janssen Scientific Affairs; Membership on Advisory Committees or Review

Panels, Board Membership, etc for Penumbra

Ronak Patel, MD: Consulting Fee from AIM Specialty Health

The following individuals have disclosed no relevant financial relationships:

Anoop Agrawal, MD

Vineet Arora, MD, MAPP

Gopi Astik, MD, MS

Anup Das, MD, PhD

Khalilah Gates, MD

Sadia Gazi, MD

Lucy Gomez Timana, MD

Elizabeth Hubbard, MD

Allison Kessler, MD, MSc

Cheryl Lee, MD

André Mansoor, MD

Jeffery Merz, MD

Ike Okwuosa, MD

Kevin O’Leary, MD, MS

Andrew Olson, MD

Niti Patel, MD, Pharm D

Sridevi Ramalingam, MD

Phillip Santoiemma, MD

Barbara Slawski, MD, MS, SFHM

Marion Stanley, MD

Anjan Tibrewala, MD, MS

Sebastian Urday, MD

James Walter, MD

All the relevant financial relationships for these individuals have been mitigated.


1. National Academies of Sciences, Engineering, and Medicine. 2015. Improving diagnosis in health care. Washington, DC: The

National Academies Press.

2. Reilly BM. Physical examination in the care of medical inpatients: an observational study. Lancet. 2003;362(9390):1100-

1105. doi:10.1016/S0140-6736(03)14464-9

3. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of 

Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines